VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
Fidelity National Information Services, Inc. vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Fidelity National Information Services, Inc.
FIS · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Fidelity National Information Services, Inc.'s moat claims, evidence, and risks.
View FIS analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Fidelity National Information Services, Inc. leads (65 / 100 vs 62 / 100 for GSK plc).
- Segment focus: Fidelity National Information Services, Inc. has 2 segments (68.1% in Banking Solutions); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Fidelity National Information Services, Inc. has 6 moat types across 3 domains; GSK plc has 4 across 3.
Primary market context
Fidelity National Information Services, Inc.
Banking Solutions
Core banking platforms and bank transaction processing software/services
Global
Banks, credit unions, commercial lenders, and other institutions
Software/platform provider and outsourced processor
68.1%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
Fidelity National Information Services, Inc. strengths
GSK plc strengths
Segment mix
Fidelity National Information Services, Inc. segments
Full profile >Banking Solutions
Oligopoly
Capital Market Solutions
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.